May 24, 2017 3:56 PM ET


Company Overview of 23andMe, Inc.

Company Overview

23andMe, Inc. operates as a personal genetics company that provides DNA analysis services. The company offers information and tools for individuals to learn about and explore their DNA. It enables individuals to discover ancestral origins and trace the lineage with a personalized analysis of DNA. The company uses Illumina HumanOmniExpress-24 format chip that comprises a custom panel of probes for detecting genetic variations. Its Personal Genome Service enables individuals to gain deeper insights into their ancestry and inherited traits. The company also sells personalized genetics kits online. The company was founded in 2006 and is based in Mountain View, California.

899 West Evelyn Avenue

Mountain View, CA 94041

United States

Founded in 2006





Key Executives for 23andMe, Inc.

Co-Founder, Chief Executive Officer and Director
President and Director
Age: 49
Chief Financial Officer and Head of Operations
Age: 53
Chief Science Officer and Head of Therapeutics
Age: 63
Chief Medical Officer
Compensation as of Fiscal Year 2016.

23andMe, Inc. Key Developments

23 & Me Presents at The NewYorkBIO 2017 Annual Conference, May-11-2017 11:30 AM

23 & Me Presents at The NewYorkBIO 2017 Annual Conference, May-11-2017 11:30 AM. Venue: New York, United States. Speakers: Angele Maki, Director of Business Development.

23andMe, Inc. Presents at The 20th Annual Milken Institute Global Conference, May-01-2017 02:30 PM

23andMe, Inc. Presents at The 20th Annual Milken Institute Global Conference, May-01-2017 02:30 PM. Venue: The Beverly Hilton, 9876 Wilshire Boulevard, Beverly Hills, CA 90210, California, United States. Speakers: Joyce Tung, Director of Research.

23andMe Receives FDA Nod to Sell Genetic Tests Directly to Consumers

23andMe announced that, for the first time, the US Food and Drug Administration said it would allow a company to sell genetic tests for disease risk directly to consumers, providing people with information about the likelihood that they could develop various conditions, including Parkinson's and Alzheimer's. The move on April 6, 2017 is a turnaround for the agency, which had imposed a moratorium in 2013 on disease tests sold by the company, 23andMe, which is based in Mountain View, California. The decision is expected to open the floodgates for more direct-to-consumer tests for disease risks, drawing a road map for other companies to do the same thing. 23andMe will now be reporting telltale markers for 10 diseases. Most, like factor XI deficiency, a blood clotting disorder, Gaucher disease type 1, an organ and tissue illness, and celiac disease are rare. Anyone who buys the $199 Ancestry and Health test from the company will automatically learn if they have mutations increasing their risk for those diseases. Risk genes for Alzheimer's and Parkinson's are treated separately. Customers will have to specifically say that they want that information. The company's website offers links to genetic counsellors for those who are weighing whether to be tested. If they want those results they will be included at no extra charge, though patients have to pay for the counselling separately.

Similar Private Companies By Industry

Company Name Region
20n Labs, Inc. United States
23andMe, Inc. United States
2C Tech Corporation, Inc. United States
3-V Biosciences, Inc. United States
3Bar Biologics Inc. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
The Advertising Council, Inc. United States
Rush University United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact 23andMe, Inc., please visit Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at